# A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

> **NCT07489885** · PHASE2 · NOT_YET_RECRUITING · sponsor: **InventisBio Co., Ltd** · enrollment: 75 (estimated)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** D-2570 Tablet
- **DRUG:** Placebo Tablets

## Key facts

- **NCT ID:** NCT07489885
- **Lead sponsor:** InventisBio Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2027-08
- **Final completion:** 2027-12
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07489885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07489885, "A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07489885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*